Fluxus
Fluxus is a leader in optofluidics, dedicated to advancing the detection, diagnosis, monitoring, and treatment of diseases through innovative systems and solutions. Founded in 2016 and acquired by Fujirebio Holdings Inc. in 2022, the company merges Silicon Valley startup ingenuity with the stability of an established multinational corporation.
With a focus on ultrasensitive detection technologies and high-value biomarkers, Fluxus aims to close significant gaps in clinical research and diagnostics. The experienced multidisciplinary team continually innovates to establish the company as the gold standard in single-molecule counting and ultrasensitive biomolecular testing.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.